Heartmate 3 fully magnetically levitated left ventricular assist device for the treatment of advanced heart failure –1 year results from the Ce mark trial
暂无分享,去创建一个
Ivan Netuka | Friedhelm Beyersdorf | Michiel Morshuis | Daniel Zimpfer | Thomas Krabatsch | Jens Garbade | Yuriy Pya | Silvana Marasco | Vivek Rao | M. Morshuis | J. Garbade | V. Rao | D. Zimpfer | F. Beyersdorf | S. Marasco | J. Schmitto | Laura Damme | Laura Damme | Jan D. Schmitto | Y. Pya | I. Netuka | T. Krabatsch | V. Rao
[1] E. Stephenson,et al. Clinical Experience With Sternotomy Versus Subcostal Approach for Exchange of HeartMate II Left Ventricular Assist Device. , 2015, The Annals of thoracic surgery.
[2] D. Rodgers,et al. Clinical hemodynamic evaluation of patients implanted with a fully magnetically levitated left ventricular assist device (HeartMate 3). , 2017, The Journal of Heart and Lung Transplantation.
[3] Takeshi Nakatani,et al. First Annual IMACS Report: A global International Society for Heart and Lung Transplantation Registry for Mechanical Circulatory Support. , 2016, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[4] M. Mehra,et al. The vexing problem of thrombosis in long-term mechanical circulatory support. , 2014, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[5] Yoshifumi Naka,et al. Results of the post-U.S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support). , 2011, Journal of the American College of Cardiology.
[6] Gregory J. Stoddard,et al. Pulsatility and the Risk of Nonsurgical Bleeding in Patients Supported With the Continuous-Flow Left Ventricular Assist Device HeartMate II , 2013, Circulation. Heart failure.
[7] J. Morgan,et al. Lessons Learned from 150 Continuous-Flow Left Ventricular Assist Devices: A Single Institutional 7 Year Experience , 2015, ASAIO journal.
[8] A. Khaghani,et al. Results of the post-market Registry to Evaluate the HeartWare Left Ventricular Assist System (ReVOLVE). , 2014, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[9] C. Bara,et al. Acquired von Willebrand syndrome in patients with a centrifugal or axial continuous flow left ventricular assist device. , 2014, JACC. Heart failure.
[10] M. Acker,et al. Pump thrombosis in the Thoratec HeartMate II device: An update analysis of the INTERMACS Registry. , 2015, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[11] Axel Haverich,et al. First implantation in man of a new magnetically levitated left ventricular assist device (HeartMate III). , 2015, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[12] N. Uriel,et al. Acquired von Willebrand syndrome after continuous-flow mechanical device support contributes to a high prevalence of bleeding during long-term support and at the time of transplantation. , 2010, Journal of the American College of Cardiology.
[13] S. Russell,et al. Advanced heart failure treated with continuous-flow left ventricular assist device. , 2009, The New England journal of medicine.
[14] G. Ewald,et al. Unexpected abrupt increase in left ventricular assist device thrombosis. , 2014, The New England journal of medicine.
[15] F. Pagani. Adverse event burden and mechanical circulatory support: Looking toward the future. , 2016, The Journal of thoracic and cardiovascular surgery.
[16] Jessica L. Howard,et al. HeartMate II Left Ventricular Assist Device Geometry on Chest Radiograph Does Not Correlate with Risk of Pump Thrombosis , 2015, ASAIO journal.
[17] N. Uriel,et al. Evolution in Mechanical Circulatory Support Are We at the Precipice of a Disruptive Innovation?* , 2017 .
[18] Nader Moazami,et al. Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device. , 2009, Journal of the American College of Cardiology.
[19] Valluvan Jeevanandam,et al. Intrapericardial Left Ventricular Assist Device for Advanced Heart Failure , 2017, The New England journal of medicine.
[20] References , 1971 .
[21] Igor Gregoric,et al. HeartWare ventricular assist system for bridge to transplant: combined results of the bridge to transplant and continued access protocol trial. , 2013, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[22] M. Mehra,et al. Evaluation of von Willebrand factor with a fully magnetically levitated centrifugal continuous-flow left ventricular assist device in advanced heart failure. , 2016, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[23] M. Morshuis,et al. Fully Magnetically Levitated Left Ventricular Assist System for Treating Advanced HF: A Multicenter Study. , 2015, Journal of the American College of Cardiology.
[24] D. Goldstein,et al. Increased Incidence of Gastrointestinal Bleeding Following Implantation of the HeartMate II LVAD , 2010, Journal of cardiac surgery.
[25] J. Cleveland,et al. Clinical trial design and rationale of the Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 (MOMENTUM 3) investigational device exemption clinical study protocol. , 2016, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[26] C. Caldeira,et al. Incidence and Risk Factor Analysis for Gastrointestinal Bleeding and Pump Thrombosis in Left Ventricular Assist Device Recipients. , 2015, Artificial organs.
[27] J. Morgan,et al. Gastrointestinal bleeding with the HeartMate II left ventricular assist device. , 2012, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[28] F. Pagani,et al. Gastrointestinal bleeding and subsequent risk of thromboembolic events during support with a left ventricular assist device. , 2012, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[29] Nader Moazami,et al. An analysis of pump thrombus events in patients in the HeartWare ADVANCE bridge to transplant and continued access protocol trial. , 2014, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[30] N. Smedira,et al. Continuous flow left ventricular assist device outcomes in commercial use compared with the prior clinical trial. , 2011, The Annals of thoracic surgery.
[31] M. Morshuis,et al. Systemic Thrombolysis Versus Device Exchange for Pump Thrombosis Management: A Single-Center Experience , 2016, ASAIO journal.
[32] M. Acker,et al. Increasing Frequency of Left Ventricular Assist Device Exchanges in the United States. , 2015, Annals of Thoracic Surgery.
[33] Gregory A. Ewald,et al. A Fully Magnetically Levitated Circulatory Pump for Advanced Heart Failure , 2017, The New England journal of medicine.
[34] O. Dur,et al. Design Rationale and Preclinical Evaluation of the HeartMate 3 Left Ventricular Assist System for Hemocompatibility , 2016, ASAIO journal.
[35] P. Eckman,et al. Gastrointestinal Bleeding during Continuous-Flow Left Ventricular Assist Device Support is Associated with Lower Rates of Cardiac Transplantation , 2015, ASAIO journal.
[36] A. Hoffmeier,et al. Initial clinical experience with the HeartWare left ventricular assist system: a single-center report. , 2013, The Annals of thoracic surgery.
[37] M. Slaughter,et al. Results of the destination therapy post-food and drug administration approval study with a continuous flow left ventricular assist device: a prospective study using the INTERMACS registry (Interagency Registry for Mechanically Assisted Circulatory Support). , 2014, Journal of the American College of Cardiology.
[38] V. Jeevanandam,et al. Gastrointestinal bleeding in recipients of the HeartWare Ventricular Assist System. , 2015, JACC. Heart failure.
[39] N. Uriel,et al. Device Exchange in HeartMate II Recipients: Long-Term Outcomes and Risk of Thrombosis Recurrence , 2015, ASAIO journal (1992).
[40] Kiyotaka Fukamachi,et al. Does pulsatility matter in the era of continuous-flow blood pumps? , 2015, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.